Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
24.6(c) 25.51(c) 25.7(c) 24.68(c) 24.53(c) Last
336 084 247 923 203 913 159 566 160 723 Volume
+4.46% +3.70% +0.74% -3.97% -0.61% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 8,33 M - -
Net income 2021 -147 M - -
Net cash position 2021 504 M - -
P/E ratio 2021 -7,90x
Yield 2021 -
Sales 2022 1,25 M - -
Net income 2022 -185 M - -
Net cash position 2022 511 M - -
P/E ratio 2022 -6,76x
Yield 2022 -
Capitalization 1 161 M 1 161 M -
EV / Sales 2021 78,9x
EV / Sales 2022 518x
Nbr of Employees 114
Free-Float 92,2%
More Financials
Company
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for patients with rare hematologic diseases and cancers. Its pipeline consists of seven product candidates, two of which it is pursuing as core product candidates for development: FT-4202 for the treatment of sickle cell disease (SCD) and other... 
More about the company
Ratings of Forma Therapeutics Holdings, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about FORMA THERAPEUTICS HOLDINGS, INC.
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 2000 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 3000 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 2500 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell Small Cap Comp..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 3000E Growth I..
CI
06/21FORMA THERAPEUTICS HOLDINGS, INC. : Submission of Matters to a Vote of Security ..
AQ
06/14FORMA THERAPEUTICS : Announces Appointment of Industry Veteran John E. Bishop, P..
PU
06/14FORMA THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers, R..
AQ
06/14Forma Therapeutics Holdings, Inc. Announces Appointment of John Bishop as Chi..
CI
06/14FORMA THERAPEUTICS : Announces Appointment of Industry Veteran John E. Bishop, P..
BU
06/11FORMA THERAPEUTICS : SVB Leerink Adjusts Forma Therapeutics Holdings PT to $54 F..
MT
06/11FORMA THERAPEUTICS : Presents New Phase 1 Data on Etavopivat (formerly referred ..
PU
06/11FORMA THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Other Events (form..
AQ
06/11FORMA THERAPEUTICS : Presents New Phase 1 Data on Etavopivat (formerly referred ..
BU
06/11Forma Therapeutics Holdings, Inc. Presents New Phase 1 Data on Etavopivat At ..
CI
More news
News in other languages on FORMA THERAPEUTICS HOLDINGS, INC.

- No features available -

More news
Analyst Recommendations on FORMA THERAPEUTICS HOLDINGS, INC.
More recommendations
Chart FORMA THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Forma Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORMA THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 24,53 $
Average target price 56,50 $
Spread / Average Target 130%
EPS Revisions
Managers and Directors
Frank D. Lee President, Chief Executive Officer & Director
Todd E. Shegog Chief Financial Officer & Senior Vice President
Peter Wirth Chairman
David N. Cook Chief Scientific Officer & Senior Vice President
Patrick Kelly Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
FORMA THERAPEUTICS HOLDINGS, INC.-29.71%1 234
MODERNA, INC.233.90%88 312
LONZA GROUP AG24.05%53 538
IQVIA HOLDINGS INC.39.02%47 022
CELLTRION, INC.-25.21%32 170
SEAGEN INC.-16.87%28 525